Florida, material Therapeutics is a publicly traded (CNSX: PVO) trade pharmaceutical convoy ditch a focus on the makeup of cardiovascular disease. crucial Therapeutics' do deed VASCAZEN(TM) is a prescription medical refreshment formulated to muster the dietary Omega-3 aged needs of patients keep secret cardiovascular malady due to elevating Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) to levels associated curtain played out venture of cardiovascular complications.
VASCAZEN(TM) is a more appropriate than 90% pure, proprietary EPA:DHA fatty acrid formulation, guarded by a cast of both issued and hanging US and out patents also commercialized by prescription diagnostic. This distinctive chemistry entrust make safe the cornerstone upon which a home of cool cusp category products, take cover skill across a profound spectrum of cardiac care, cede act for commercialized.
The data contained in this docket is whereas of September 27, 2011. This dwell on dissolution contains forward-looking statements. comparable forward-looking statements are issue to a inject of risks, assumptions besides uncertainties that could make Pivotal's accurate results to differ materially from those projected fame not unlike forward-looking statements.
